Literature DB >> 23591556

Postprandial lipaemia and vascular disease.

Genovefa Kolovou1, Teik Chye Ooi.   

Abstract

PURPOSE OF REVIEW: In this review we discuss the postprandial pathophysiological mechanisms that promote vascular disease, the evidence for a role of postprandial lipaemia (PPL) in vascular disease and the effect of modifiable and nonmodifiable factors in PPL. RECENT
FINDINGS: PPL refers to the dynamic changes in serum lipids and lipoproteins (mainly in serum triglycerides) that occur after a fat load or a meal. Recent data indicate that postprandial or nonfasting triglyceride levels are better predictors of cardiovascular risk, suggesting that efficiency of postprandial handling of triglyceride-rich lipoproteins plays a role in the causation of vascular disease.
SUMMARY: The recent finding that postprandial serum triglyceride levels are even better than fasting serum triglyceride levels as predictors of vascular disease indicate that it is better to measure an index of triglyceride-rich lipoproteins (in most cases serum triglyceride levels) in the postprandial period than in the postabsorptive fasting state. Moreover, by the time the postabsorptive state is reached, some of these proatherogenic triglyceride-rich lipoprotein changes may be missed in the measurement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591556     DOI: 10.1097/HCO.0b013e3283606971

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  12 in total

1.  Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.

Authors:  Charlotte Koopal; A David Marais; Jan Westerink; Yolanda van der Graaf; Frank L J Visseren
Journal:  J Lipid Res       Date:  2017-09-19       Impact factor: 5.922

2.  Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients.

Authors:  Pablo Perez-Martinez; Juan F Alcala-Diaz; Edmon K Kabagambe; Antonio Garcia-Rios; Michael Y Tsai; Javier Delgado-Lista; Genovefa Kolovou; Robert J Straka; Francisco Gomez-Delgado; Paul N Hopkins; Carmen Marin; Ingrid Borecki; Elena M Yubero-Serrano; James E Hixson; Antonio Camargo; Michael A Province; Javier Lopez-Moreno; Fernando Rodriguez-Cantalejo; Francisco J Tinahones; Dimitri P Mikhailidis; Francisco Perez-Jimenez; Donna K Arnett; Jose M Ordovas; Jose Lopez-Miranda
Journal:  J Clin Lipidol       Date:  2016-06-01       Impact factor: 4.766

3.  Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.

Authors:  Yunpeng Guan; Xiaoyu Hou; Peipei Tian; Luping Ren; Yong Tang; An Song; Jiajun Zhao; Ling Gao; Guangyao Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

4.  Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study.

Authors:  Vana Kolovou; Olga Diakoumakou; Athanasia K Papazafiropoulou; Niki Katsiki; Elisabeth Fragopoulou; Ioannis Vasiliadis; Dimitris Degiannis; Leonidas Duntas; Smaragdi Antonopoulou; Genovefa Kolovou
Journal:  Open Cardiovasc Med J       Date:  2018-07-31

5.  Acute Freeze-Dried Mango Consumption With a High-Fat Meal has Minimal Effects on Postprandial Metabolism, Inflammation and Antioxidant Enzymes.

Authors:  Crystal O'Hara; Babajide Ojo; Sam R Emerson; Ashley J Simenson; Sandra Peterson; Penelope Perkins-Veazie; Mark E Payton; Janice Hermann; Brenda J Smith; Edralin A Lucas
Journal:  Nutr Metab Insights       Date:  2019-08-19

6.  Determination of optimal cut-off points after a high-fat meal corresponding to fasting elevations of triglyceride and remnant cholesterol in Chinese subjects.

Authors:  Jin Xu; Yan-Qiao Chen; Shui-Ping Zhao; Ling Liu
Journal:  Lipids Health Dis       Date:  2019-11-25       Impact factor: 3.876

Review 7.  MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis.

Authors:  Emma L Solly; Catherine G Dimasi; Christina A Bursill; Peter J Psaltis; Joanne T M Tan
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

Review 8.  Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?

Authors:  Yoshifumi Saisho
Journal:  Int J Mol Sci       Date:  2014-10-13       Impact factor: 5.923

Review 9.  Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.

Authors:  Chary Lopez-Pedrera; Nuria Barbarroja; Alejandra Mª Patiño-Trives; Maria Luque-Tévar; Carmen Torres-Granados; Mª Angeles Aguirre-Zamorano; Eduardo Collantes-Estevez; Carlos Pérez-Sánchez
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

10.  Postprandial Hyperlipemia is an Indication for Additional Risk in Sitosterolemia.

Authors:  Misa Ito; Katsunori Ikewaki
Journal:  J Atheroscler Thromb       Date:  2018-10-11       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.